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There is increasing evidence that myelin disruption is related to cognitive decline in Alzheimer's disease
(AD). In the CNS, myelin is produced by oligodendrocytes, which are generated throughout life by adult
oligodendrocyte progenitor cells (OPCs), also known as NG2-glia. To address whether alterations in
myelination are related to age-dependent changes in OPCs, we analyzed NG2 and myelin basic protein
(MBP) immunolabelling in the hippocampus of 3Tg-AD mice at 6 and 24 months of age, compared with
non-Tg age-matched controls. There was an age-related decrease in MBP immunostaining and OPC
density, together with a decline in the number of OPC sister cells, a measure of OPC replication. Notably,
the loss of myelin and OPC sister cells occurred earlier at 6 months in 3xTg-AD, suggesting accelerated
aging, although there was not a concomitant decline in OPC numbers at this age, suggesting the observed
changes in myelin were not a consequence of replicative exhaustion, but possibly of OPC disruption or
senescence. In line with this, a key finding is that compared to age-match controls, OPC displayed
marked morphological atrophy at 6 months in 3xTg-AD followed by morphological hypertrophy at
24 months, as deduced from significant changes in total cell surface area, total cell volume, somata
volume and branching of main processes. Moreover, we show that hypertrophic OPCs surround and
infiltrate amyloid-b (Ab) plaques, a key pathological hallmark of AD. The results indicate that OPCs
undergo complex age-related remodeling in the hippocampus of the 3xTg-AD mouse model. We
conclude that OPC disruption is an early pathological sign in AD and is a potential factor in accelerated
myelin loss and cognitive decline.
 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Alzheimer's disease (AD) is a neurodegenerative disease char-
acterised by age-related decline in learning, memory and cognition.
Neuropathological hallmarks of AD are amyloid b (Ab) plaques and
neurofibrillary tangles (NFTs). In addition, myelin disruption isd Biomedical Sciences, Uni-
fax: þ44 (0)23 9284 2396.
.
er Inc. This is an open access articlprominent in AD (Bartzokis, 2011), while myelin loss may predict
AD onset and neurodegenerative changes in humans (Brickman et
al., 2015), as well as in animal models of AD (Desai et al., 2009).
Thus, disruption of myelination is a feature of AD, although the
underlying causes are unresolved.
In the CNS, myelin is produced by oligodendrocytes, which are
generated from oligodendrocyte progenitor cells (OPCs) (Rivers et
al., 2008; Zhu et al., 2011), also known as NG2-glia or synanto-
cytes (Butt et al., 2005). OPCs are identified by their expression of
the membrane proteoglycan NG2 (Cspg4) (Stallcup, 1981), and aree under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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adult brain, OPCs slowly divide asymmetrically to form daughter
cells that are responsible for OPC self-renewal and for generating
new oligodendrocytes for myelin repair and for myelination of new
connections important in learning (Hughes et al., 2018;McKenzie et
al., 2014; Xiao et al., 2016; Young et al., 2013). In addition, OPCs
readily respond to CNS pathology by a characteristic morphological
remodeling and increased NG2 expression (Levine, 2016; Rodríguez
et al., 2016). Notably, OPCs display increased senescence and
disruption in the aging brain (Neumann et al., 2019; Segel et al.,
2019; Sim et al., 2002), and this may be aggravated in human and
mouse AD (Dong et al., 2018; Li et al., 2013; Nielsen et al., 2013;
Zhang et al., 2019). These studies suggest that age-related changes
in OPCs are related to a reduction in myelination in AD (Butt et al.,
2019).
The triple transgenic mouse model of AD (3xTg-AD) harbors
presenilin 1 (PS1; M146 V), amyloid precursor protein (APP; Swe),
and tau (P301 L) transgenes, and displays progressive AD-like pa-
thology and cognitive impairments in an age-related manner
(Belfiore et al., 2019; Oddo et al., 2003; Olabarria et al., 2010).
Immunohistochemical, electron microscope and imaging studies
have shown myelin disruption in the hippocampus of 3Tg-AD
mice in 6 month-old mice (Desai et al., 2009, 2010; Nie et al., 2019),
concomitant with the appearance of Ab plaques (Oddo et al., 2003).
Here, we have performed a detailed examination of age-related
changes in OPC in the hippocampus of 3xTg-AD mouse. Morpho-
logical analysis (Olabarria et al., 2010) of total cell surface area, total
cell volume, somata volume and branching of main processes
demonstrated that OPC display a marked morphological atrophy at
6 months in 3xTg-AD. Morphological atrophy was collateral to a
decline in the numerical density of OPC daughter cells and
decreased myelin immunostaining in the hippocampus. In contrast,
at 24 months in 3xTg-AD OPCs undergo a marked morphological
hypertrophy and cluster around Ab plaques with astrocytes. This
study identifies complex changes in OPC morphology that are
related to the pathogenesis of AD.
2. Materials and methods
2.1. Animals and tissues
All animal procedures were carried out in accordance with the
United Kingdom Animals (Scientific Procedures) Act of 1986 under
licence from the Home Office. All efforts were made to reduce the
number of animals by following the 3 Rs. The procedure for
generating 3xTg-AD mice has been described previously (Oddo et
al., 2003; Rodríguez et al., 2008). The 3xTg-AD mouse line har-
bors the APP Swedish mutations K670 N/M671 L, the presenilin-1
M146 V mutation and the tau P301 L mutation in a C57BL6 mice
background, and all 3xTg-AD and non-Tg control mice were ob-
tained by crossing homozygous breeders. The animals were housed
in same-sex cages, kept in 12 hours light-dark cycles with free ac-
cess to food and water independent of the diet. at these ages that
the amyloid and tau pathologies emerge resembling the human
Alzheimer's disease progression. Mice aged 6 and 24 months were
used, because 3xTg-AD mice have been shown to exhibit myelin
disruption at 6 months prior to deposition of extracellular Ab pla-
ques, which are prominent at 24 months of age (Desai et al., 2010;
Olabarria et al., 2010). Male 3xTgAD and non-transgenic control
mice were anesthetized with intra-peritoneal injection of sodium
pentobarbital (50 mg kg) at 6 and 24 months of age. The mice were
perfused through the aortic arch with 3.75% acrolein (TAAB, Berk-
shire, UK) in a solution of 2% paraformaldehyde (Sigma, Cambridge,
UK) and 0.1 M phosphate buffer (PB) pH 7.4, followed by 2%
paraformaldehyde.2.2. Immunohistochemistry
Brains were removed and cut into 4- to 5-mm coronal slabs of
tissue containing the entire rostrocaudal extent of the hippocam-
pus. Brain sections were postfixed in 2% paraformaldehyde for
24 hours and kept in 0.1 M PB, pH 7.4. Coronal sections of the brain
were cut into 40 mm thickness using a vibrating microtome
(VT1000S; Leica, Milton Keynes, UK). Free floating brain sections in
0.1 M PB, pH 7.4, were collected and stored in cryoprotectant so-
lution containing 25% sucrose and 3.5% glycerol in 0.05 M PB at pH
7.4. Coronal sections at levels 1.58 ⁄ 2.46 mm (hippocampus)
posterior to the Bregma were selected for immunohistochemistry
according to the mouse brain atlas. The sections were incubated for
30 minutes in 30% methanol in 0.1 M PB and 3% hydrogen peroxide
(H2O2) (Sigma). Sections were then rinsed with 0.1 M PB for 5 mi-
nutes and placed in 1% sodium borohydride (Sigma) for 30 minutes.
The sections were then washed with PB profusely before rinsing in
0.1 M Trizma base saline (TS) for 10 minutes. Brain sections were
then incubated in 0.5% bovine serum albumin (BSA) (Sigma) in
0.1 M TS and 0.25% Triton (Sigma) for 30 minutes. Sections were
incubated for 24 hours at room temperature in primary antibody:
rabbit anti-NG2, 1:400 (Millipore); rat anti-MBP, 1:400 (Millipore);
mouse anti-Ab, 1:1000 (Covance). Tissues were then washed 3
times again in TS and incubated with the appropriate secondary
antibody (AlexaFluor 488, AlexaFluor 568, 1:400, Life Technologies)
diluted in blocking solution for 1 hour at room temperature on an
orbital shaker and protected from the light. Following secondary
antibody incubation, tissues were washed 2 times with TS and 3
times with PB before being covered with mounting medium and
glass coverslips ready for imaging.
2.3. Confocal microscopy and image analysis
Images were captured using a Zeiss Axiovert LSM 710 VIS40S
confocal microscope and maintaining the acquisition parameters
constant to allow comparison between samples within the same
experiment. Acquisition of images was done with x20 objective for
cell counts and analysis of MBP immunostaining; x40 objective was
used to examine relationships between OPCs and Ab plaques; x100
objective was used for OPC 3D reconstruction and morphological
analysis, with z-stacks formed by 80e100 single plains with an
interval of 0.3 mm.
2.4. Quantification
Cell counts for OPCs were performed in a constant field of view
(FOV) of 100 mm x100 mm in projected images of z-stacks of 10 optic
sections with 1 mm interval. Morphological analyses of NG2-glia
was performed as previously used for astrocytes in the 3xTg-AD
mouse (Olabarria et al., 2010), using the Cell Analyst program and
morphological calculations detailed in (Chvátal et al. 2007). In brief,
the Cell Analyst program builds a detailed 3-D reconstruction of the
cell based on a series of high resolution confocal z-stacks 0.3 mm
apart, which defines the precision of the analysis (Chvátal et al.,
2007); we used 5 digital filters (average 3  3, convolution, gauss
5  5, despeckle, simple objects removal) and a threshold of 50 to
determine the surface and volume of the NG2-positive OPCs
(Olabarria et al., 2010). Relative density of MBP immunostaining
was measured from a constant field of view using ImageJ; a
threshold was set from negative controls and parameters were kept
constant to avoid experimental errors and/or bias. Results are
expressed as mean  SEM and statistical differences were deter-
mined by one-way ANOVA and NewmaneKeuls multiple compar-
ison post-hoc analysis or unpaired t-tests, as appropriate, using
Graphpad Prism5.0.
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3.1. Age-related changes in OPC numbers and MBP
immunolabelling
Disruption of oligodendrocytes and myelin is an early event in
the hippocampus of 3xTg-ADmice (Desai et al., 2009, 2010), but it is
unclear how this is related to age-related changes in OPCs, which
are responsible for life-long generation of myelinating oligoden-
drocytes (Young et al., 2013). To examine this, we performed im-
munostaining for NG2 and MBP in 6 and 24 month old 3xTg-AD,
compared to age-matched controls (Fig.1). NG2-positive OPCs were
widely distributed throughout the hippocampus of both 3xTg-AD
and non-Tg mice (Fig. 1Ai-iv), and cell counts indicated there was a
decrease in the overall numerical density of OPCs between
6 months and 24 months in both 3xTg-Ad and non-Tg controls
(Fig. 1Av, unpaired t-tests). In addition, we observed an age-related
decrease in MBP immunostaining between 6 months and
24 months in non-Tg controls (Fig 1Bi, iii), however this decrease
occurred earlier in 3xTg-AD at 6 months (Fig. 1Biii), without further
change at 24 months (Fig. 1Biv). Quantitative analysis confirmed
that MBP immunofluorescence intensity was significantly less in 6-
month 3xTg-AD hippocampus compared to age-matched non-Tg
controls (Fig. 1Bv; p < 0.001) and equivalent to the level seen in 24-
month controls. The results demonstrate a decline in OPCs andMBP
with physiological aging, but although OPC numerical densityFig. 1. Age-dependent changes in OPCs and myelin in the hippocampus of 3xTg-AD and ag
immunolabelled with the OPC marker NG2 (Ai-iv) and the myelin marker MBP (Bi-iv). Scale b
MBP immunoreactive intensity (Bv) in the hippocampus; data are mean  SEM, *p < 0.05,was unaltered in 3xTg-AD, the loss of MBP was significantly
accelerated.
3.2. Age-related changes in OPC sister cells
Similarly to stem cells, OPCs self-maintain by undergoing
asymmetric division and recently divided cells occur as closely
associated duplets or triplets of ‘daughter cells’ that either self-
sustain OPCs or proceed to differentiate into oligodendrocytes
(Boda et al., 2014). Hence, the frequency of OPC duplets/triplets is a
measure of cell division and OPC regenerative potential (Boda et al.,
2014). To examine this in aging, NG2 immunostaining was per-
formed together with nuclear labeling with Hoechst blue to high-
light groups of 2 or more juxtaposed OPC daughter cells (Fig. 2).
OPC doublets and triplets were prominent throughout the hippo-
campus in 6 months non-Tg controls, exemplified in the CA1
(Fig. 2A). Quantitation shows a significant decrease in OPC daughter
cells between 6 and 24 months in non-Tg controls in the hippo-
campus overall (Fig. 2B; p < 0.001, unpaired t-tests), and regional
analyses demonstrated equivalent decline in the dentate gyrus
(DG), and CA1 and CA3 regions (Fig. 2CeE). At 6 months, the
number of OPC daughter cells was significantly less in 3xTg-AD
hippocampus than age-matched controls (Fig. 2B; p < 0.001), and
declined to the level seen at 24-months in controls (Fig. 2BeE).
There was no further change in OPC daughter cells at 24 months in
3xTg-AD, which was equivalent to age-matched controlse-matched non-Tg controls. (Ai-iv, B-iv) Confocal images illustrating the hippocampus
ars ¼ 50 mm. (Av, Bv) Bar graphs showing the numerical density of NG2þ OPCs (Av) and
**p < 0.01, unpaired t-tests.
Fig. 2. Age-dependent changes in OPC daughter cells in hippocampus of 3xTg-AD and age-matched non-Tg controls. (A) Confocal images illustrating OPC duplets (arrows), in the
CA1 area of the hippocampus of 3xTg-AD mice immunolabelled for NG2 (green) and counterstained with the nuclear marker Hoechst blue (blue). Maximum intensity z-stack
projection (Ai), together with single z-section (Aii) and orthogonal section through the x-x plane (Aiii), showing juxtaposed duplets of recently divided OPC daughter cells. Scale
bars ¼ 20 mm in Ai and 10 mm in Aii, Aiii. (BeE) Quantification of sister cells per constant field of view (FOV) in the hippocampus overall (B), the dentate gyrus (DG) (C), CA1 (D) and
CA3 (E); data are mean  SEM from 3 sections per animal, n ¼ 3 animals. *p < 0.05, **p < 0.01, ***p < 0.001, unpaired t-tests. (For interpretation of the references to color in this
figure legend, the reader is referred to the Web version of this article.)
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physiological aging that is observed at a younger age in 3xTg-AD.
3.3. Age-related changes in OPC morphology
Changes in the cellular morphology of OPCs is a characteristic of
the response to CNS pathology (Levine, 2016, Rodríguez et al., 2016)
and has been reported in human AD and mouse models of the
disease (Dong et al., 2018, Li et al., 2013, Nielsen et al., 2013, Zhang
et al., 2019). To examine whether this occurs in 3xTg-AD, we per-
formed a detailed morphological analysis of NG2 immunostained
OPCs in the hippocampus at 6 and 24 months (Fig. 3), using the Cell
Analyst program and morphological parameters detailed by(Chvátal et al. 2007), as described previously for astrocytes in the
3xTg-AD model (Rodríguez et al., 2013). The results show no sig-
nificant difference in themorphology of OPCs at 6 and 24months in
non-Tg controls (Fig. 3A and C), also confirmed by quantification of
multiple cellularmorphological parameters (Fig. 3EeH). In contrast,
at 6 months OPCs displayed marked morphological atrophy in
3xTg-AD, compared to controls (Fig. 3A and B), exhibiting a sig-
nificant decrease in overall cell size and size of cell somata
(Fig. 3EeH). Conversely, at 24 months OPCs displayed marked hy-
pertrophy in 3xTg-AD, compared to age-matched controls (Fig. 3C
and D), and 6 months 3xTg-AD (Fig. 3B), with significantly larger
cell volume and surface area (Fig. 3E and H) and of cell somata
volume and surface area (Fig. 3F and G). It is notable that OPC have
Fig. 3. Age-dependent changes in OPC morphology in the CA1 hippocampus of 3xTg-AD and age-matched non-Tg controls. (AeD) Representative confocal images of NG2
immunopositive OPCs in the CA1 region of the hippocampus, illustrating in magenta the outline used for analysis of individual cells using the Cell Analyst program (Chvátal et al.,
2007); scale bars ¼ 10 mm. (EeH) Quantification of OPC total cell volume (E), cell body surface area (F), cell body volume (G) and total cell surface area (H); data are mean  SEM
from 25 cells from 3 sections per mouse, where n ¼ 3 or 4). *p < 0.05, **p < 0.01, ****p < 0.0001 unpaired t-tests.
I. Vanzulli et al. / Neurobiology of Aging 94 (2020) 130e139134circular domains in the x-y plane, but are extremely flat in the z-
plane, and their somata are not spherical, but instead appear as a
‘fjord-like’ in the x-y planes, and extremely thin in the z-plane
(Fig. 2Aii, Aiii), hence surface-volume relationships are not simple
cubic as for a sphere. Overall, the surface-volume ratio is 10 inOPC, as it is in astrocytes, although OPC are much smaller and the
overall values are correspondingly 2e3 times smaller than equiv-
alent measurements in astrocytes (Chvátal et al., 2007; Olabarria
et al., 2010). The results demonstrate OPCs go through complex
morphological changes in 3xTg-AD that are not observed in natural
I. Vanzulli et al. / Neurobiology of Aging 94 (2020) 130e139 135aging, characterised by shrinkage in early AD, followed by a clear
hypertrophy at late stages, indicative of a reactive metamorphosis.3.4. OPCs are closely localised with Ab plaques in 3xTg-AD
Neuropathological changes and Ab plaque load become signifi-
cantly greater with age in 3xTg-AD mice in AD-relevant brain re-
gions, including the hippocampus (Belfiore et al., 2019, Oddo et al.,
2003). There is evidence from in vitro studies that Ab is toxic for
OPCs (Desai et al., 2011) and induces morphological condensation
(Nielsen et al., 2013). However, we did not observe a decrease in
OPC in 3xTg-AD and cells were hypertrophic at 24 months. We
therefore performed double immunfluorescence labeling toFig. 4. Relationships between OPCs and Ab plaques in the hippocampus of 24-month 3
immunostained for NG2 (green) and Ab (red). (A) Overview of the association of OPCs with A
for NG2 (Aii) and Ab (Aiii). (B) OPCs clustering around Ab plaque in maximum intensity z-sta
OPC within the boundary of multiple Ab plaques. (D) OPC embedded within an Ab plaque i
50 mm in A, 25 mm in B and 20 mm in C, D. (For interpretation of the references to color inexamine the relations between OPCs and Ab plaques in 24 months
3xTg-AD (Fig. 4). The results demonstrate that hypertrophic OPCs
are adjacent to Ab plaques throughout the hippocampus (Fig. 4A).
Higher magnification imaging in the CA1 hippocampal area dem-
onstrates the intimate relationships between OPCs and Ab plaques
(Fig. 4BeD). Large Ab plaques are circumscribed by OPCs and
infiltrated by their processes (Fig. 4B). OPCs were observed to be
located both between multiple plaques that they contact (Fig. 4C),
as well as being embedded within Ab plaques (Fig. 4D). In the
cortex, intraneuronal and vascular Ab immunoreactivity was
prominent in 24 months 3xTg-AD (Fig. 5A and C), and OPCs were
directly apposed to these, surrounding them with their processes
(Fig. 5B and D). The results demonstrate that OPCs are intimatelyxTg-AD. Confocal images of coronal brain sections from 24-month 3xTg-AD double
b in the CA1 area of the hippocampus, with merged image (Ai) and indvidual channels
ck projection (Bi) and single z-section (Bii). (C) Maximum intensity z-stack projection of
n maximum intensity z-stack projection (Di) and orthogonal section (Dii). Scale bars ¼
this figure legend, the reader is referred to the Web version of this article.)
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study in human AD (Zhang et al., 2019).
3.5. Interrelations between OPCs and astrocytes in Ab plaques
In 3xTg-AD, astrocyte hypertrophy is associated with Ab plaques
(Olabarria et al., 2010), and there is evidence astrocytes play a role
in the clearance and removal of Ab (Nielsen et al., 2010). The close
associations of OPC with Ab plaques demonstrated above stimu-
lated us to examine their interrelationships with astrocytes in the
24-month 3xTg-AD hippocampus (Fig. 6). Triple immunostaining
for NG2, GFAP and Ab shows that both astrocytes and OPCs are
densely distributed throughout the hippocampus in association
with Ab deposits (Fig. 6A), and the processes of OPCs and astrocytes
overlap extensively, contacting and infiltrating proximal Ab plaques
(Fig. 6B). Furthermore, in the hippocampus of 24 months 3xTg-AD
we rarely observed cells co-immunostained for NG2 and GFAP
(Fig. 6C and D). NG2 positive astrocytes have been reported in hu-
man AD in individuals with high Ab plaque load (Nielsen et al.,
2013), and comparison with NG2þ/GFAP OPCs and NG2/
GFAPþ astrocytes in the same field of view in our study indicates
NG2þ/GFAPþ cells had a morphology more akin to astrocytes than
OPCs (Fig. 6D). Our results demonstrate that OPCs and astrocytes
cluster around the same Ab plaques in 3xTg-AD.
4. Discussion
Age-related loss of myelin is a feature of normal aging and has
been shown to be exacerbated in human AD (Bartzokis, 2011;
Brickman et al., 2015) and in multiple animal models of AD-like
pathology (Desai et al., 2009; Dong et al., 2018). Here, we confirmFig. 5. Relationship of OPCs with intraneuronal and vascular Ab in 3xTg-AD. Confocal imag
OPCs are directly apposed to Ab containing neurones (A, B) and blood vessels (C, D). Scale ba
this figure legend, the reader is referred to the Web version of this article.)previous observations (Desai et al., 2009, 2010), by showing that
compromisedmyelination is evident at 6months of age in 3xTg-AD,
to a degree comparable to that observed at 24 months in natural
aging. The maintenance of myelination in the adult brain is an ul-
timate function of OPCs, which divide and regenerate oligoden-
drocytes more slowly in the aging brain (Psachoulia et al., 2009;
Young et al., 2013). Our data shows an age-related decrease in the
number of OPC daughter cells occurred significantly earlier, at
6months, in 3xTg-AD, suggesting OPC self-renewal is compromised
at early stages of AD-like pathology. Notably, OPCs displayed
marked cellular shrinkage at 6 months in 3xTg-AD. In contrast,
OPCs were hypertrophic at 24 months in 3xTg-AD and, together
with astrocytes, were closely associated with Ab plaques (Li et al.,
2013; Nielsen et al., 2010). Our findings indicate complex changes
in OPCs are important markers for early and late stages of AD-like
pathology, which may be a major factor in myelin loss.
Imaging studies in 3xTg-AD show pronounced myelin changes
in the fimbria, which acts as the major output tract of the hippo-
campus (Nie et al., 2019), and our results support evidence that
myelination is reduced in 3xTg-AD (Desai et al., 2009, 2010, 2011;
Mastrangelo and Bowers, 2008). These results in 3xTg-AD mice
correlate well with imaging and postmortem studies in human AD
demonstrating widespread abnormalities in oligodendrocytes and
myelin, including reduced MBP (Bartzokis, 2011; De Rossi et al.,
2016; Ihara et al., 2010; McKenzie et al., 2017; Nasrabady et al.,
2018; Roher et al., 2002). Indeed, white matter changes are an
early feature of human AD (Fischer et al., 2015; Hoy et al., 2017), and
the premature loss of MBP immunostaining observed in our study is
consistent with myelin loss being an early event in AD pathology
and cognitive decline (Butt et al., 2019; Nasrabady et al., 2018;
Wang et al., 2020). Certainly, myelin disruption is coincident withes of 24 months 3xTg-AD cortex double immunostained for NG2 (green) and Ab (red).
rs ¼ 100 mm in A, C, and 20 mm in B, D. (For interpretation of the references to color in
Fig. 6. Interrelations between OPCs and astrocytes with Ab plaques in the 24-month 3xTg-AD hippocampus. Confocal images of CA1 region triple immunostained for NG2 (green),
GFAP (red) and Ab (blue). (A) OPCs and astrocytes are uniformly distributed in the CA1 layer with overlapping process domains. (B) OPCs and astrocytes are associated with the
same Ab plaques, with processes intertwined within Ab plaques. (C) Large Ab plaque containing cells co-expressing NG2 and GFAP (arrows, colocalization appears yellow). (D) High
magnification maximum intensity z-stack projection of an NG2þ/GFAPþ cell (asterisk), illustrating merged image (D), together with individual channels for NG2 (Di) and GFAP (Dii).
Scale bars ¼ 50 mm in A, 10 mm in B, D, and 30 mm in C. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
I. Vanzulli et al. / Neurobiology of Aging 94 (2020) 130e139 137the earliest signs of cognitive impairment and neuropathology in
3xTg-AD (Billings et al., 2005; Oddo et al., 2003). Furthermore,
myelin disruption has been shown to result in axonal and neuronal
degeneration (Stassart et al., 2018), and myelin injury and loss of
oligodendrocytes in AD is associated with axon degeneration and
amyloid plaques (Mitew et al., 2010; Zhan et al., 2015). The causes of
myelin loss in AD are likely to include direct Ab toxicity (Desai et al.,
2011), as well as glutamate, metabolic and iron dyshomeostasis
(Ndayisaba et al., 2019;Wang and Reddy, 2017; Yin et al., 2016). Our
results indicate disruption of OPCs is another key event that may
contribute to myelin loss in early AD.
At early stages of disease progression in 3xTg-AD, OPCs dis-
played a striking morphological atrophy, manifested by decreased
cell surface area and volume, concomitant with a >30% decrease in
OPC daughter cells, a measure of their recent cell division (Boda
et al., 2014). The asymmetric division of OPCs is critical for self-
replication and the life-long generation of new myelinating oligo-
dendrocytes (Dimou et al., 2008; Kang et al., 2010; Rivers et al.,
2008; Zhu et al., 2008). Hence, the early atrophy of OPCs and
apparent decrease in self-renewal indicates disruption of OPCs may
be a key factor in the accelerated loss of myelin in 3xTg-AD. Notably,
OPCs extend processes to contact glutamatergic synapses in the
hippocampus (Bergles et al., 2000), and glutamatergic signaling
promotes OPC proliferation and differentiation (Chen et al., 2018;
Wake et al., 2011). It is significant, therefore, that synaptic
dysfunction, in particular disruption of glutamatergic signaling, is
an early event in 3xTg-AD (Chakroborty et al., 2019; Clark et al.,
2015; Oddo et al., 2003), and is a major component of human AD
(Crimins et al., 2013). Astroglial glutamate homeostasis is also
dysregulated in 3xTg-AD (Kulijewicz-Nawrot et al., 2013; Olabarria
et al., 2010), which would further exacerbate glutamate signaling
onto OPCs. The atrophy of OPC processes is contemporaneous with
disruption of synaptic signaling, suggesting this is an importantfactor in the observed decline in OPC self-renewal and reduced
capacity for replacing myelin lost in AD (Rivera et al., 2016). Overall,
OPC numbers did not decline until later ages in 3xTg-AD, implying
the accelerated decline in myelination in 3xTg-AD was not directly
related to a loss of OPCs, but may reflect reduced differentiation and
OPC senescence (Zhang et al., 2019). At later stages of disease
progression OPCs displayed a marked hypertrophy in 3xTg-AD,
with increased cell volume and surface area, thicker processes and
enlarged cell bodies, characteristic of an injury response in OPCs
(Ong and Levine, 1999). Hypertrophic OPCs contacted Ab plaques
together with astrocytes, which have been described previously
(Rodríguez et al., 2008). These findings are consistent with OPCs
being relatively resistant to Ab (Horiuchi et al., 2012), and there is
evidence OPCs are involved in Ab clearance (Li et al., 2013; Nielsen
et al., 2010).
In conclusion, the results demonstrate that OPCs undergo
complex changes that are related to acceleratedmyelin loss in 3xTg-
AD. This study highlights the importance of OPCs in AD
pathogenesis.
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